Effect of coenzyme Q10 versus placebo as an adjuvant therapy on pain in patients with painful diabetic neuropathy
Phase 3
- Conditions
- Painful diabetic neuropathy.Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecifiedE08.40
- Registration Number
- IRCT20120215009014N385
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 116
Inclusion Criteria
Age of 18 to 70 years,
Type 2 diabetes for at least one year,
Painful diabetic neuropathy,
Exclusion Criteria
Pregnancy or breastfeeding,
Foot ulcer or infection,
Hemoglobin A1C equal to or less than 9,
Cerebrovascular diseases or discopathy,
Taking anti-inflammatory medications,
Using alcohol or opioids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method